Recruiting A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers NCT06805617 Conditions Adenocarcinoma, Adenoid Cystic Carcinoma, Advanced Salivary Gland Carcinoma, +14 more Locations Brigham and Women's Hospital — Boston, Massachusetts, United States Dana-Farber Cancer Institute — Boston, Massachusetts, United States View Trial Details
Active, Not Recruiting Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial NCT04704661 Conditions Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more Locations UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California, United States Los Angeles General Medical Center — Los Angeles, California, United States USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California, United States View all 23 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing NCT05924256 Conditions Advanced Salivary Gland Carcinoma Locations Dongmei Ji — Shanghai, China View Trial Details
